Your Health Plan:
Your Health Plan:
Not SelectedEDARBI (azilsartan kamedoxomil) is a brand-name prescription drug for treatment of Hypertensive disease, Cerebrovascular accident and Myocardial Infarction. EDARBI is a angiotensin 2 receptor blocker. It is available in the form of oral tablet.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $130-170.
Other alternatives to EDARBI may include: